Hair back from the dead (2020-2026) 1/23/2026
A user successfully regrew hair using 1mg finasteride, switching to 0.5mg dutasteride, and maintaining 5mg oral minoxidil, with significant improvements noted after switching to dutasteride. The user experienced shedding phases but ultimately achieved regrowth and is now comfortable without wearing a hat.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity Dutasteride shedding phase while in Minoxidil
The user experienced hair shedding with finasteride and found minoxidil helpful for regrowth but insufficient alone. They are considering dutasteride but are concerned about potential shedding similar to their experience with finasteride.
community The non-linear nature of hair regrowth on Fin/Min
Hair regrowth with treatments like finasteride, minoxidil, and dutasteride is not linear; shedding phases can occur, causing temporary setbacks. Consistent treatment and evaluating progress at longer intervals, like every 6 months, is recommended for better results.
community 3 months on topical min + fin + Redensyl and hair is worse. Nonstop shedding & dry flaky scalp
A 25-year-old male is experiencing worsening hair loss after 3 months of using topical minoxidil, finasteride, and Redensyl, with users suggesting patience, potential hormonal factors, and considering alternative treatments like dutasteride and oral minoxidil. Shedding is noted as a common phase, indicating potential future hair regrowth.
community Second shed or losing the battle? Finasteride and minoxidil
The user experienced initial regrowth with finasteride and minoxidil but is now facing increased hair thinning, possibly due to a second shedding phase. They are considering increasing finasteride dosage or adding dutasteride, despite availability issues, and have started microneedling.
community Come back was real and thanking the community, God, Fin, minoxidil and dut lmao 🙏🏼
A 25-year-old male shared his successful hair regrowth journey using oral minoxidil, topical minoxidil, finasteride, and dutasteride. He experienced initial regrowth, a shedding phase, and then improved hair density, advising others not to panic during shedding and to act early on hair loss.
community Secondary shedding, 6 months into oral minoxidil/finasteride 3mg chewables
The user experienced significant hair regrowth and increased density after six months of using oral minoxidil and finasteride chewables, despite going through a secondary shedding phase. The only side effect mentioned was restlessness, and the user feels healthier overall.
Related Research
6 / 6 results
research B‐ RAF , naevi and melanoma: a complex relationship
Male hair loss is mainly due to thinner hair, not less hair.
research The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study
Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.
research Hair diameter vs. hair density in male androgenetic alopecia
Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.
research Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study
In this study of men with androgenetic alopecia, dutasteride was shown to be more effective than finasteride in increasing hair count and reversing hair miniaturization over 24 weeks, with both treatments displaying similar side effect profiles.
research Nonsurgical Therapy for Hair Loss
This review discusses current and emerging medical therapies for androgenetic alopecia but reports no new clinical findings, emphasizing the importance of stabilizing the condition as a complement to surgical hair restoration.
research Safety concerns when using novel medications to treat alopecia
This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.